In ovarian cancer A2780/DDP cell line, THP can increase the sensitivity of ovarian cancer cells to cisplatin by regulating the miR-93/PTEN/AKT pathway (Gong et al., 2019). The gene discussed is AKT1; the disease is ovarian carcinoma.